Media
|
Contact
|
Disclaimer
|
Careers
About us
Vision & Mission
Goal & Strategy
Values
Board of Directors
Management
Business Development
Oncology
Cancer at a glance
Belinostat
Mode of action
Clinical use
Safety profile
Indications and clinical program
Belinostat clinical studies
NCI- and Investigator Sponsored Trials
Belinostat abstracts - ASCO 2013
Science
Histone Deacetylase (HDAC)
Scientific publications
Glossary
Collaborators
Academic collaborators
Partners
Investor
Media
News and Announcements
Photo Gallery
Media and Photo Gallery
Media enquiries should be directed to
CEO Anders Fink Vadsholt
.